BioSpace News Archive

Career Advice

Last Minute Interview Tips To Prepare for Your Job Interview

This smooth 24 hours of preparation for your job interview should ensure a long run when you get that job offer. Here are last minute interview tips to hone your skills.

November 25, 2019
·
6 min read
·
Katharine Hansen, PhD
Drug Development

Genentech’s Tecentriq-Avastin Combo Improves Survival in Liver Cancer

Tecentriq is the company’s PD-L1 checkpoint inhibitor. Avastin is an antibody that binds to VEGF and interferes with tumor blood supply.

November 25, 2019
·
2 min read
·
Mark Terry
Labour manifesto sets out to improve access to treatments, but leading dementia research charity says more needs to be done

Alzheimer’s Research UK, the UK’s leading dementia research charity, has welcomed the Labour Party’s manifesto pledge to improve access to future treatments for conditions like dementia.

November 25, 2019
·
2 min read
Deals

Novartis Buys The Medicines Company: A $9.7 Billion Gamble on a PCSK9 Cholesterol Drug

“We are excited about entering into an agreement to acquire The Medicines Company as inclisiran is a potentially transformational medicine that reimagines the treatment of atherosclerotic heart disease and familial hypercholesterolemia,” said Vas Narasimhan, chief executive officer of Novartis.

November 25, 2019
·
3 min read
·
Mark Terry
Business

HALIX Celebrates Grand Opening of its State-of-the-Art cGMP Facility

Official inauguration ceremony of the new facility for the development and manufacturing of biopharmaceuticals

November 25, 2019
·
4 min read
Biotech Bay

Diagenode to Offer Single-Cell ATAC-Seq Services Featuring Bio-Rad’s Droplet Digital Technology

Diagenode, Inc. and Bio-Rad Laboratories, Inc. announced a partnership in which Diagenode will offer Single-Cell ATAC-Seq Services, featuring Bio-Rad’s Droplet Digital technology, to help advance epigenomics research.

November 25, 2019
·
4 min read
Business

FLAMMA CEO given Chinese Citizenship for business efforts in China

Flamma SpA is proud to announce that Mr. Gian Paolo Negrisoli, Flamma CEO, has been granted Honorary Dalian Citizenship for his friendship to China and his contribution in promoting economic exchanges and cooperation through Flamma Honkai.

November 25, 2019
·
2 min read
Drug Development

Vaccitech provides update on clinical progress for its two Phase 2 Universal Influenza studies

Vaccitech progresses clinical development of Universal Influenza A Vaccine (VTP-100) in Belgium and Australia and expects top-line data in early 2020

November 25, 2019
·
4 min read
Policy

A!maginostic Partners A*STAR’s Institute Of Molecular And Cell Biology To Establish A New Joint Lab Of Excellence For Smart Digital And Multiplex Pathology

The collaboration will use Image Processing and Artificial Intelligence/Machine Learning to revolutionise pathology practice and provide more precise cancer diagnostic assays

November 25, 2019
·
6 min read
Healx commits $20M to launch Rare Treatment Accelerator programme; appoints Dr Bruce Bloom as Chief Collaboration Officer to lead initiative

Healx’s Rare Treatment Accelerator, investing up to the value of $1M in AI and drug discovery resources per selected rare disease project, is now open for applications

November 25, 2019
·
5 min read